CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in DNLI — Denali Therapeutics Inc.
CIK 884546
SAN FRANCISCO, CA
Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,020,242
+$8,838,182 QoQ
Shares Held
1,244,955
+3.1% QoQ
Ownership
0.779%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 290 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. DNLI ranks #47 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,020,242 | 1,244,955 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,182,060 | 1,207,399 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,819,842 | 1,200,475 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,718,095 | 1,151,384 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,773,705 | 1,056,019 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $20,960,055 | 1,028,462 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $29,590,545 | 1,015,810 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,597,038 | 1,059,304 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $21,362,530 | 1,041,059 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $21,610,155 | 1,006,997 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $20,239,247 | 981,059 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $25,603,790 | 867,631 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $19,268,997 | 836,328 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,267,876 | 836,673 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $22,430,707 | 730,880 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,528,692 | 731,522 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,655,754 | 704,251 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $31,986,674 | 717,190 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $35,504,288 | 703,752 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $50,219,954 | 640,234 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $32,290,963 | 565,516 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $41,310,264 | 493,198 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $17,429,145 | 486,440 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,394,728 | 471,246 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $7,330,946 | 418,672 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||